Article

TNFSF9 is associated with favor tumor immune microenvironment in patients with renal cell carcinoma who are treated with the combination therapy of nivolumab and ipilimumab

2024-03-29

Abstract excerpt

Combination therapy of nivolumab and ipilimumab (NIVO + IPI) for metastatic renal cell carcinoma (mRCC) has shown efficacy, but approximately 20% of patients experience disease progression in the early stages of treatment. No useful biomarkers have been reported to date. Therefore, it is desirable to identify biomarkers to predict treatment response in advance. We examined the tumor microenvironment (TME)-related...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 84bfc435-a5be-5b5c-8dd1-8e1823c70432
DOI: 10.21203/rs.3.rs-4161771/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

TNFSF9 is associated with favor tumor immune microenvironment in patients with renal cell carcinoma who are treated with the combination therapy of nivolumab and ipilimumabDOI 10.21203/rs.3.rs-4161771/v1Read

Multi-omics Analysis of Tumor Necrosis Factor Superfamily 4 Reveals Its Prognostic Value and T Cell Exhaustion Feature in CancerSemantic proximity Read

Identification and Validation of TNFRSF4 as a High-profile Biomarker for Prognosis and Immunomodulation in Endometrial CarcinomaSemantic proximity Read

Integrated analysis of polytranscriptomics reveals TNFSF ligand genes in pancreatic cancer prognosis and immune regulationSemantic proximity Read

Thirteen tumor necrosis factor receptor superfamily gene expression in malignancies and their clinical relevance to immunotherapy: a pan-cancer analysisSemantic proximity Read

TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder CarcinomaSemantic proximity Read

Analysis of genetic signatures of tumor microenvironment yields insight into mechanisms of resistance to immunotherapySemantic proximity Read

Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint InhibitorsSemantic proximity Read

Microenvironment of metastasis reveals key predictors of PD-1 blockade response in renal cell carcinomaSemantic proximity Read

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.Semantic proximity Read

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read

Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.Semantic proximity Read

Tumor cytokine profile of renal cell carcinoma patientsSemantic proximity Read